Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.
CONCLUSIONS: Adjuvant chemotherapy could be associated with a survival benefit for patients with stage I OCCC.
PMID: 29751993 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Nasioudis D, Mastroyannis SA, Albright BB, Haggerty AF, Ko EM, Latif NA Tags: Gynecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clear Cell Carcinoma | Databases & Libraries | Ovarian Cancer | Ovaries | Study